ALDH7A1

protein-coding

aldehyde dehydrogenase 7 family member A1, the group of Aldehyde dehydrogenases

Gene summary

The protein encoded by this gene is a member of subfamily 7 in the aldehyde dehydrogenase gene family. These enzymes are thought to play a major role in the detoxification of aldehydes generated by alcohol metabolism and lipid peroxidation. This particular member has homology to a previously described protein from the green garden pea, the 26g pea turgor protein. It is also involved in lysine catabolism that is known to occur in the mitochondrial matrix. Recent reports show that this protein is found both in the cytosol and the mitochondria, and the two forms likely arise from the use of alternative translation initiation sites. An additional variant encoding a different isoform has also been found for this gene. Mutations in this gene are associated with pyridoxine-dependent epilepsy. Several related pseudogenes have also been identified. [provided by RefSeq, Jan 2011]

Previous symbols:
  • ATQ1

MANE transcript

NM_001182.5

Inheritance

AR, AD

ClinVar variants

P:213U:283B:216

Top phenotype

Epilepsy, early-onset, 4, vitamin B6-dependent

gnomAD constraint

pLI —, LoF o/e 0.93

Max pathogenic AF

—

Genomic locus

chr5:126,531,200-126,595,362

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~64.2 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

pyridoxine-dependent epilepsy caused by ALDH7A1 mutantSTRONG

Inheritance Pattern: AR

Disease ID:MONDO:0020741

Submitter: Labcorp Genetics (formerly Invitae)

pyridoxine-dependent epilepsy caused by ALDH7A1 mutantDEFINITIVE

Inheritance Pattern: AD

Disease ID:MONDO:0020741

Submitter: Ambry Genetics

pyridoxine-dependent epilepsy caused by ALDH7A1 mutantSTRONG

Inheritance Pattern: AR

Disease ID:MONDO:0020741

Submitter: PanelApp Australia

pyridoxine-dependent epilepsy caused by ALDH7A1 mutantDEFINITIVE

Inheritance Pattern: AR

Disease ID:MONDO:0020741

Submitter: G2P

pyridoxine-dependent epilepsyDEFINITIVE

Inheritance Pattern: AR

Disease ID:MONDO:0009945

Submitter: ClinGen

The relationship between ALDH7A1 and pyridoxine-dependent epilepsy (PDE) was evaluated using the ClinGen Clinical Validity Framework as of June 28th, 2019. Patients with this same condition have also been reported as having folinic acid responsive seizures (Gallagher et al, 2009, PMID 19142996). ALDH7A1 encodes alpha-aminoadipic acid semialdehyde dehydrogenase, also known as antiquitin, which converts alpha-aminoadipic acid semialdehyde (AASA) to alpha-aminoadipic acid, a critical step in lysine catabolism. Variants in ALDH7A1 causing PDE were first reported by Mills et al, 2006 (PMID 16491085). Since then, over eighty PDE-associated variants have been reported in ALDH7A1 (see Pena et al, 2017, PMID 30058881, for review). Data from 10 patients with 9 unique variants (missense, nonsense, frameshift, and splicing) from 2 publications were curated (Mills et al, 2006, PMID 16491085; Salomons et al, 2007, PMID 17721876). Additional cases are available in the literature but the maximum score for genetic evidence (12 points) has been reached. This gene-disease relationship is supported by the biochemical function of alpha-aminoadipic acid semialdehyde dehydrogenase (antiquitin), which is consistent with the biochemical and clinical features of the disease (Mills et al, 2006, PMID 16491085), expression in brain (Jansen et al, 2014; PMID 24122892), functional studies of missense variants (Coulter-Mackie et al, 2012, PMID 22784480), and the phenotype observed in two CRISPR-generated aldh7a1 zebrafish models (Pena et al, 2017; PMID 29061647; Zabinyakov et al, 2017, PMID 29053735). Additional experimental data supporting the gene-disease relationship is available but the maximum score for experimental evidence (6 points) has been reached. Data curated by Illumina is included in this curation. In summary, ALDH7A1 is definitively associated with autosomal recessive PDE. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. The classification was approved by the ClinGen Aminoacidopathy Gene Curation Expert Panel on July 26, 2019.

pyridoxine-dependent epilepsyDEFINITIVE

Inheritance Pattern: AR

Disease ID:MONDO:0009945

Submitter: Illumina

The ALDH7A1 gene is located on chromosome 5 at 5q23.2 and encodes the aldehyde dehydrogenase 7 family member A1 protein. This enzyme plays a key role in lysine metabolism and may indirectly regulate inhibitory neurotransmission in the brain by affecting pyridoxal 5’-phosphate-dependent synthesis. The ALDH7A1 gene was first reported in relation to autosomal recessive pyridoxine-dependent epilepsy in 2006 (16491085: Mills et al. 2006). Evidence supporting this gene-disease relationship includes case level data and experimental data. From a selection of the literature, at least eight variants, including missense, splicing, stop-gained, and one synonymous with a splicing effect, have been reported in either a homozygous or compound heterozygous state in seven individuals with pyridoxine dependent epilepsy (16491085 Mills et al. 2006; 17721876: Salomons et al. 2007). Considerably more case-level evidence is available in the literature (30043187: Coughlin et al. 2018), but the maximum score for genetic evidence (12 pts) has been reached. The mechanism of disease is homozygous loss of function; missense variants demonstrate an absent or reduced recombinant enzyme activity (22784480: Coulter-Mackie et al. 2012). A zebrafish Aldh7A1 knock out model recapitulates the biochemical deficiency, seizure phenotype, and mechanism of disease, as well as amelioration of disease features with pyridoxine treatment (29061647: Pena et al. 2017). In summary, the ALDH7A1 gene is definitively associated with autosomal recessive pyridoxine dependent epilepsy. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time.

pyridoxine-dependent epilepsySUPPORTIVE

Inheritance Pattern: AR

Disease ID:MONDO:0009945

Submitter: Orphanet

Clinical Genomic Database (CGD)

Epilepsy, early-onset, 4, vitamin B6-dependentAR

Manifestation: Neurologic

Intervention: Neurologic

Rationale: Individuals frequently present in the neonatal period with seizures (neonatal lactic acidosis and hypoglycemia have also been described), and the seizures, though otherwise refractory to other anti-epileptics, can typically be controlled via medical management (daily pyridoxine monotherapy), though the condition may still impact longer-term developmental manifestations

Refs: 13133562; 14131641; 3977296; 16159904; 16075246; 16491085; 17068770; 17721876; 21704546; 20301659; 22529283; 22728861; 22804844; 23054014; 28331464Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to ALDH7A1 variants in ClinVar

18 Conditions Cataloged
Pyridoxine-dependent epilepsyTotal: 899
not providedTotal: 230
not specifiedTotal: 120
Inborn genetic diseasesTotal: 117
ALDH7A1-related disorderTotal: 43
SeizureTotal: 7
EpilepsyTotal: 5
See casesTotal: 4

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_001182.5. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
2
clinvar
1
clinvar
8
clinvar
200
clinvar
1
clinvar
212
missense
23
clinvar
75
clinvar
261
clinvar
15
clinvar
374
nonsense
19
clinvar
11
clinvar
2
clinvar
32
start loss
2
clinvar
2
frameshift
21
clinvar
13
clinvar
4
clinvar
38
splice donor/acceptor (+/-2bp)
22
clinvar
26
clinvar
6
clinvar
54
Total871262832151712

Highest pathogenic variant AF is 0.0005130239

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 82 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_001182.5RefSeqNP_001173.218MANE Select
ENST00000409134.8EnsemblENSP00000387123.318MANE Select
NM_001201377.2RefSeqNP_001188306.118Standard
NM_001202404.2RefSeqNP_001189333.216Standard

Model Organisms & Knockout Phenotypes

Observed phenotypic effects in mouse and zebrafish models

Gene / ModelOrganismObserved Phenotype
aldh7a1Danio rerio

Structure: pharyngeal arch cartilage

Quality: morphology

abnormal

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Tryptophan metabolism - Homo sapiens (human)
  • Pyruvate metabolism - Homo sapiens (human)
  • Arginine and proline metabolism - Homo sapiens (human)
  • Glycolysis / Gluconeogenesis - Homo sapiens (human)
  • Glycerolipid metabolism - Homo sapiens (human)

Biological Process

  • cellular aldehyde metabolic process
  • lysine catabolic process
  • sensory perception of sound
  • glycine betaine biosynthetic process from choline
  • choline catabolic process

Molecular Function

  • aldehyde dehydrogenase (NAD) activity
  • L-aminoadipate-semialdehyde dehydrogenase activity
  • protein binding
  • betaine-aldehyde dehydrogenase activity
  • glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity

Cellular Component

  • nucleus
  • mitochondrion
  • mitochondrial matrix
  • cytosol
  • extracellular exosome

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000409134
Coding exons
18
Length
53578
Individuals with no LoFs
125652
Homozygous LoFs
0
Heterozygous LoFs
96
Defined
125748
p
0.000382
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense0.3682782960.9400.00001493497
Missense (PolyPhen)95119.140.79741449
Synonymous-0.1851081061.020.000005711051
Loss of Function0.3693537.40.9350.00000216400

Population LoF Frequency

PopulationCAFp-valueStatus
African0.0000620.000062rare
Latino/Admixed American0.000260.00026rare
Ashkenazi Jewish00.0absent
East Asian0.000220.00022rare
Finnish0.0000920.000092rare
European (Non-Finnish)0.000410.00041rare
South Asian0.000990.00098rare
Other0.000500.00049rare

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Multifunctional enzyme mediating important protective effects. Metabolizes betaine aldehyde to betaine, an important cellular osmolyte and methyl donor. Protects cells from oxidative stress by metabolizing a number of lipid peroxidation-derived aldehydes. Involved in lysine catabolism. {ECO:0000269|PubMed:16491085, ECO:0000269|PubMed:20207735}.;

Recessive Scores

pRec
0.378

Intolerance Scores

LoFtool
0.398
RVIS EVS
-0.47
RVIS percentile EVS
23.43

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
S
Essential (gene trap)
N
Indispensability pred.
E
Indispensability score
0.687

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.